Quintiles Transnational Holdings Inc (Q)

Q on New York Consolidated

24 Dec 2014
Price Change (% chg)

$0.01 (+0.02%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for Q


Quintiles Transnational Holdings Inc., is a provider of biopharmaceutical development services and commercial outsourcing services. The Company operates in two segments: Product Development and Integrated Healthcare Services. The Company’s Product Development segment operates as a contract research organization (CRO) focused... (more)


Beta: --
Market Cap (Mil.): $7,603.37
Shares Outstanding (Mil.): 127.85
Dividend: --
Yield (%): --


  Q Industry Sector
P/E (TTM): 23.04 151.53 38.61
EPS (TTM): 2.58 -- --
ROI: 20.75 -0.59 18.27
ROE: -- -1.72 19.14
Search Stocks

UPDATE 2-Product development unit woes overshadow Quintiles profit beat

* Co raises 2014 service revenue, adjusted EPS forecast (Adds details from conference call, analysts' comments and share movement)

31 Jul 2014

REFILE-Quintiles profit more than doubles on higher services revenue growth

July 31 - Quintiles Transnational Holdings Inc , the world's largest medical contract research provider, said its quarterly profit more than doubled, helped by higher growth in its integrated healthcare services segment.

31 Jul 2014

BRIEF-Basilea Pharmaceutica - enters into agreement with Quintiles for commercialization of Zevtera/Mabelio in Europe

July 21 - Basilea Pharmaceutica AG : * Says entered into agreement with Quintiles for commercialization of

21 Jul 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: Stock Traders Daily
Provider: New Constructs, LLC
Provider: ValuEngine, Inc.
Provider: Pechala's Reports

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks